AddLife AB (publ) (ALIF-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AddLife AB (publ) (ALIF-B) has a cash flow conversion efficiency ratio of 0.163x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr888.00 Million ≈ $95.56 Million USD) by net assets (Skr5.45 Billion ≈ $586.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
AddLife AB (publ) - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how AddLife AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AddLife AB (publ) total liabilities for a breakdown of total debt and financial obligations.
AddLife AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AddLife AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gudang Garam Tbk
JK:GGRM
|
0.018x |
|
Solvac S.A.
BR:SOLV
|
-0.001x |
|
Mirae Asset Daewoo Co Ltd Pref
KO:00680K
|
-0.338x |
|
SPG Co. Ltd
KQ:058610
|
0.063x |
|
Outokumpu Oyj
HE:OUT1V
|
0.015x |
|
Navios Maritime Partners LP Unit
NYSE:NMM
|
0.034x |
|
Enerpac Tool Group Corp
NYSE:EPAC
|
0.032x |
|
Dehua TB New Decoration Material Co Ltd
SHE:002043
|
-0.276x |
Annual Cash Flow Conversion Efficiency for AddLife AB (publ) (2012–2025)
The table below shows the annual cash flow conversion efficiency of AddLife AB (publ) from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of AddLife AB (publ).
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr5.45 Billion ≈ $586.18 Million |
Skr1.39 Billion ≈ $149.80 Million |
0.256x | +23.90% |
| 2024-12-31 | Skr5.31 Billion ≈ $571.33 Million |
Skr1.09 Billion ≈ $117.84 Million |
0.206x | +32.34% |
| 2023-12-31 | Skr4.96 Billion ≈ $533.78 Million |
Skr773.00 Million ≈ $83.19 Million |
0.156x | -14.77% |
| 2022-12-31 | Skr4.97 Billion ≈ $534.96 Million |
Skr909.00 Million ≈ $97.82 Million |
0.183x | -22.33% |
| 2021-12-31 | Skr4.29 Billion ≈ $461.77 Million |
Skr1.01 Billion ≈ $108.71 Million |
0.235x | -53.16% |
| 2020-12-31 | Skr1.89 Billion ≈ $203.43 Million |
Skr950.10 Million ≈ $102.25 Million |
0.503x | +85.31% |
| 2019-12-31 | Skr1.48 Billion ≈ $158.86 Million |
Skr400.40 Million ≈ $43.09 Million |
0.271x | +42.37% |
| 2018-12-31 | Skr931.70 Million ≈ $100.27 Million |
Skr177.50 Million ≈ $19.10 Million |
0.191x | -31.49% |
| 2017-12-31 | Skr748.00 Million ≈ $80.50 Million |
Skr208.00 Million ≈ $22.38 Million |
0.278x | +50.00% |
| 2016-12-31 | Skr716.90 Million ≈ $77.15 Million |
Skr132.90 Million ≈ $14.30 Million |
0.185x | -45.41% |
| 2015-12-31 | Skr346.60 Million ≈ $37.30 Million |
Skr117.70 Million ≈ $12.67 Million |
0.340x | -25.74% |
| 2014-12-31 | Skr263.30 Million ≈ $28.34 Million |
Skr120.40 Million ≈ $12.96 Million |
0.457x | +35.58% |
| 2013-12-31 | Skr271.60 Million ≈ $29.23 Million |
Skr91.60 Million ≈ $9.86 Million |
0.337x | -16.59% |
| 2012-12-31 | Skr293.30 Million ≈ $31.56 Million |
Skr118.60 Million ≈ $12.76 Million |
0.404x | -- |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and labo… Read more